1999
DOI: 10.1034/j.1399-0039.1999.530112.x
|View full text |Cite
|
Sign up to set email alerts
|

CTLA4 promoter and exon 1 dimorphisms in multiple sclerosiso

Abstract: The human cytotoxic T-lymphocyte-associated protein 4 (CTLA4) gene may be a candidate susceptibility gene in multiple sclerosis (MS). In this study the distribution of the dimorphisms of exon 1 (+49 A/G) and promoter (-318 C/T) regions of the CTLA4 gene was analysed in 296 unrelated Norwegian MS patients and 271 matched controls by polymerase chain reaction and restriction fragment length polymorphism. The frequency of the exon 1 (+49) A-G genotype was increased in patients (57%) compared with controls (44%) (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
11
0

Year Published

2003
2003
2014
2014

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 142 publications
(12 citation statements)
references
References 21 publications
1
11
0
Order By: Relevance
“…Over 100 single-nucleotide polymorphisms (SNPs) have been identified in CTLA-4 gene regions, and some of these SNPs were found to be related to immune-mediated diseases including type 1 diabetes mellitus [[45]], multiple sclerosis [[46]], systemic lupus erythematosus (SLE) [[47]], rheumatoid arthritis [[48],[49]], Hashimoto's thyroiditis, and Graves' disease [[45]]. However, some of the studies showed conflicting results in the association of CTLA-4 gene polymorphisms and autoimmune diseases [[50]-[52]].…”
Section: Reviewmentioning
confidence: 99%
“…Over 100 single-nucleotide polymorphisms (SNPs) have been identified in CTLA-4 gene regions, and some of these SNPs were found to be related to immune-mediated diseases including type 1 diabetes mellitus [[45]], multiple sclerosis [[46]], systemic lupus erythematosus (SLE) [[47]], rheumatoid arthritis [[48],[49]], Hashimoto's thyroiditis, and Graves' disease [[45]]. However, some of the studies showed conflicting results in the association of CTLA-4 gene polymorphisms and autoimmune diseases [[50]-[52]].…”
Section: Reviewmentioning
confidence: 99%
“…The last elongation step was extended to 5 min. Phenotyping of three SNPs, two in the 900 bp fragment and one in the 481 bp fragment of the CTLA-4 gene, were made using the RFLP technique (for conditions see table 1) as described by Harbo et al [12] and Howard et al [26]. All digested products were electrophoresed on 2% agarose gel.…”
Section: Methodsmentioning
confidence: 99%
“…DNA was extracted from blood leukocytes on an Invisorb Spin Mini-Kit following the manufacturer’s instructions (Invitek). Two fragments of the CTLA-4 gene were amplified in a T3 thermal cycler (Biometra, Germany) using two pairs of primers [12, 26]. The forward primer 5′ TCT TTT CCg CCT ATT TTC AgT T 3′ and reverse primer 5′ CCC Tgg AAT ACA gAg CCA Gc 3′ gave a product of 900 bp encompassing two single nucleotide polymorphisms (SNPs), –318 C→T (rs5742909) and +49 A→G (rs231775).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…At least three genetic polymorphisms have been reported in the human CTLA-4 gene: one in the promoter region at position −318 consisting of a C/T transition,[15] a second in position +49 of exon 1 that lies in an A/G transition resulting in a threonine (Thr) or alanine (Ala) dimorphism,[16] and a third in the 3’ untranslated region with variable lengths of a dinucleotide (AT)n repeat. [17] Several studies have shown an association between an A/G single nucleotide polymorphism (SNP) in exon 1, position +49 of the CTLA-4 gene, and autoimmune diseases such as type 1 diabetes,[1820] multiple sclerosis,[21] Grave's disease,[22] HLA-DR4-rheumatoid arthritis,[23] and celiac disease. [24] However, studies on the polymorphisms of the CTLA-4 gene in IBD have shown conflicting results in different populations.…”
mentioning
confidence: 99%